Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Akron City Hospital
mi
from
Akron, OH
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Aultman Hospital Cancer Center at Aultman Health Foundation
mi
from
Canton, OH
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Aultman Hospital Cancer Center at Aultman Health Foundation
mi
from
Canton, OH
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Charles M. Barrett Cancer Center at University Hospital
mi
from
Cincinnati, OH
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Charles M. Barrett Cancer Center at University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
South Pointe Hospital
mi
from
Cleveland, OH
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
South Pointe Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Columbus
mi
from
Columbus, OH
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Dayton
mi
from
Dayton, OH
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Oklahoma
mi
from
Tulsa, OK
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Oklahoma
mi
from
Tulsa, OK
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
St. Luke's Hospital and Health Network - Bethlehem
mi
from
Bethlehem, PA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
St. Luke's Hospital and Health Network - Bethlehem
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - MainLine Health
mi
from
Wynnewood, PA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - MainLine Health
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Wellspan Health - York Cancer Center
mi
from
York, PA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Wellspan Health - York Cancer Center
mi
from
York, PA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Kent County Memorial Hospital
mi
from
Warwick, RI
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Kent County Memorial Hospital
mi
from
Warwick, RI
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Upstate Carolina
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Eastern Virginia Medical School
mi
from
Norfolk, VA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Eastern Virginia Medical School
mi
from
Norfolk, VA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Puget Sound Oncology Consortium
mi
from
Seattle, WA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Puget Sound Oncology Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Northwest
mi
from
Tacoma, WA
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Northwest
mi
from
Tacoma, WA
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
Camden-Clark Memorial Hospital
mi
from
Parkersburg, WV
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
Camden-Clark Memorial Hospital
mi
from
Parkersburg, WV
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated:  7/11/2016
St. Michael's Hospital - Toronto
mi
from
Toronto,
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
MENSTRUAL CYCLE AND SURGICAL TREATMENT OF BREAST CANCER
Status: Enrolling
Updated: 7/11/2016
St. Michael's Hospital - Toronto
mi
from
Toronto,
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan-Kettering Cancer Center at Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
mi
from
Rockville Centre, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
mi
from
Sleepy Hollow, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Ochsner
mi
from
New Orleans, LA
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CentraCare Clinic
mi
from
Saint Cloud, MN
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Quain & Ramstad Clinic, P.C.
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Altru Health Systems
mi
from
Grand Forks, ND
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated:  7/12/2016
Saskatchewan Cancer Agency
mi
from
Regina,
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer
Status: Enrolling
Updated: 7/12/2016
Saskatchewan Cancer Agency
mi
from
Regina,
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
Howard University Cancer Center
mi
from
Washington,
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
Howard University Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated:  7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy
Status: Enrolling
Updated: 7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials